BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6787798)

  • 1. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.
    Chesebro B; Wehrly K; Cloyd M; Britt W; Portis J; Collins J; Nishio J
    Virology; 1981 Jul; 112(1):131-44. PubMed ID: 6787798
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the FMR antigen.
    Lilly F; Nathenson SG
    Transplant Proc; 1969 Mar; 1(1):85-9. PubMed ID: 4332534
    [No Abstract]   [Full Text] [Related]  

  • 3. Nature and complexity of the FMR antigenic system.
    Bismuth A; Kremsdorf D; Debré P; Levy JP
    Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic control of the ascites form of murine adenocarcinoma 755. II. Tumor immunity associated with a Friend--Moloney--Ra,scher-type virus.
    Collins JJ; Roloson G; Haagensen DE; Fischinger PJ; Wells SA; Holder W; Bolognesi DP
    J Natl Cancer Inst; 1978 Jan; 60(1):141-52. PubMed ID: 203701
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 6. The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses.
    Nowinski RC; Lostrom ME; Tam MR; Stone MR; Burnette WN
    Virology; 1979 Feb; 93(1):111-26. PubMed ID: 219593
    [No Abstract]   [Full Text] [Related]  

  • 7. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines.
    Cloyd MW; Bolognesi DP; Bigner DD
    Cancer Res; 1977 Mar; 37(3):922-30. PubMed ID: 65219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of anti-MuLV cytotoxic T lymphocytes in the AKR.H-2b and AKR.H-2b:Fv-1b mouse strains.
    Wegmann KW; Blank KJ; Green WR
    Cell Immunol; 1988 May; 113(2):308-19. PubMed ID: 2834071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
    Cloyd MW; Evans LH
    J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural immunity to endogenous oncornaviruses in mice.
    Ihle JN; Hanna MG
    Contemp Top Immunobiol; 1977; 6():169-74. PubMed ID: 194747
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias.
    Schäfer W; Schwarz H; Thiel HJ; Wecker E; Bolognesi DP
    Virology; 1976 Dec; 75(2):401-18. PubMed ID: 795137
    [No Abstract]   [Full Text] [Related]  

  • 19. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens.
    Longstreth JD; Ihle JN; Hanna MG
    Ann N Y Acad Sci; 1976; 276():343-57. PubMed ID: 68698
    [No Abstract]   [Full Text] [Related]  

  • 20. Serological analysis of immune response to friend virus-induced leukemia.
    Ting CC; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1676-83. PubMed ID: 4134291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.